Rocket Pharmaceuticals, Inc.

RCKT

CIK 0001281895 · last filing Jul 6, 2026

Insider signal

trades dated in the last 90 days · non-derivative only

142,142 bought / 0 sold

net +142,142 sh

buys: 6
sells: 0
insiders active: 6

Filing tape

Filed Mon, Jul 6, 2026

Wong Roderick — Director · 10% owner
+27,832 sh
- Granted27,832Common Stock→ 75,499 heldtrade dated Jun 18, 2026
- Granted78,960Stock Option (Right to Buy)→ 78,960 heldtrade dated Jun 18, 2026
Fong Peter — Director
+22,862 sh
- Granted22,862Common Stock→ 76,195 heldtrade dated Jun 18, 2026
- Granted64,860Stock Option (Right to Buy)→ 64,860 heldtrade dated Jun 18, 2026
Dolsten Mikael — Director
+22,862 sh
- Granted22,862Common Stock→ 67,082 heldtrade dated Jun 18, 2026
- Granted64,860Stock Option (Right to Buy)→ 64,860 heldtrade dated Jun 18, 2026
Malik Fady Ibraham — Director
+22,862 sh
- Granted22,862Common Stock→ 52,862 heldtrade dated Jun 18, 2026
- Granted64,860Stock Option (Right to Buy)→ 64,860 heldtrade dated Jun 18, 2026
Southwell David P — Director
+22,862 sh
- Granted22,862Common Stock→ 54,522 heldtrade dated Jun 18, 2026
- Granted64,860Stock Option (Right to Buy)→ 64,860 heldtrade dated Jun 18, 2026
Boess Carsten — Director
+22,862 sh
- Granted22,862Common Stock→ 52,862 heldtrade dated Jun 18, 2026
- Granted64,860Stock Option (Right to Buy)→ 64,860 heldtrade dated Jun 18, 2026

Insiders on this tape

Wong RoderickDirector · 10% owner
Fong PeterDirector
Dolsten MikaelDirector
Malik Fady IbrahamDirector
Southwell David PDirector
Boess CarstenDirector

Informational data only — not investment advice.

The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.

All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.